Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Touyun Tech Group ( (HK:1332) ) has shared an announcement.
Touyun Biotech Group Limited has issued a supplemental announcement detailing a comprehensive investment policy designed to guide all of its financial investment activities, emphasising prudent, disciplined and value-accretive capital deployment to generate sustainable long-term returns and enhance shareholder value. The policy introduces strict quantitative limits on portfolio concentration and single-investment exposure, mandates a minimum allocation to highly liquid assets, bans high-risk speculative products, and sets a target annualised return of about 15% per investment, while requiring clear exit strategies and systematic re-evaluation of underperforming holdings, thereby reinforcing risk management, governance and financial flexibility for the group and its stakeholders.
The most recent analyst rating on (HK:1332) stock is a Hold with a HK$0.09 price target. To see the full list of analyst forecasts on China Touyun Tech Group stock, see the HK:1332 Stock Forecast page.
More about China Touyun Tech Group
Touyun Biotech Group Limited, incorporated in Bermuda and listed in Hong Kong, operates as a biotech-focused group that manages its capital and financial assets alongside its core businesses. The company and its subsidiaries maintain a diversified asset base, balancing operational needs with an active portfolio of financial investments governed by formal policies and board-level oversight.
Average Trading Volume: 16,233,873
Technical Sentiment Signal: Sell
Current Market Cap: HK$252.5M
For an in-depth examination of 1332 stock, go to TipRanks’ Overview page.